Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3 | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder | Recruiting | Phase 3 | 2026-10-07 | NCT06716021 | |
| The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Paroxysmal Supraventricular Tachycardia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder, ventricular tachycardia | Recruiting | Phase 2 | 2026-07-21 | NCT05763953 |